Initial insulin therapy in children and adolescents with type 1 diabetes mellitus. 2010

Dieter Weitzel, and Dieter Weitzela, and Ulla Pfeffer, and Ulla Pfeffera, and Axel Dost, and Antje Herbst, and Antje Herbstc, and Ina Knerr, and Reinhard Holl
German Clinic for Diagnostic, Children's and Adolescent's Outpatient Centre, Wiesbaden, Germany.

OBJECTIVE The aim of the study was to define parameters that influence the initial insulin dosage in young subjects with type 1 diabetes regarding the amount of daily insulin, the ratios of basal and prandial insulin, and the insulin/carbohydrate ratios. METHODS We used a computer-based registry (with prospectively collected data) in Germany and Austria, a software for the management and data documentation of diabetic patients (DPV), to analyze the initial insulin therapy in 2247 children with newly diagnosed type 1 diabetes to identify factors that influence diabetes therapy within the first 10 d. RESULTS For both genders, glucosylated hemoglobin A1c (HbA1c), blood pH at diabetes onset, and pubertal status are the major factors determining the initial insulin dosage calculated as the amount of daily insulin per kilogram body weight (kg), the basal and prandial insulin dose per kilogram, and day and the insulin/carbohydrate ratios for meals. The frequency of hypoglycemia correlated with increasing quotient of applied to calculated insulin dosage. CONCLUSIONS The predictive factors of insulin requirement may exert beneficial effects on the assessment and adjustment of insulin therapy in young diabetic subjects at disease onset. On the basis of a multiple, linear regression, we suggest a formula to calculate the initial insulin therapy.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D012042 Registries The systems and processes involved in the establishment, support, management, and operation of registers, e.g., disease registers. Parish Registers,Population Register,Parish Register,Population Registers,Register, Parish,Register, Population,Registers, Parish,Registers, Population,Registry
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus

Related Publications

Dieter Weitzel, and Dieter Weitzela, and Ulla Pfeffer, and Ulla Pfeffera, and Axel Dost, and Antje Herbst, and Antje Herbstc, and Ina Knerr, and Reinhard Holl
April 2015, Indian journal of endocrinology and metabolism,
Dieter Weitzel, and Dieter Weitzela, and Ulla Pfeffer, and Ulla Pfeffera, and Axel Dost, and Antje Herbst, and Antje Herbstc, and Ina Knerr, and Reinhard Holl
April 2014, Paediatric drugs,
Dieter Weitzel, and Dieter Weitzela, and Ulla Pfeffer, and Ulla Pfeffera, and Axel Dost, and Antje Herbst, and Antje Herbstc, and Ina Knerr, and Reinhard Holl
April 1999, Diabetes, nutrition & metabolism,
Dieter Weitzel, and Dieter Weitzela, and Ulla Pfeffer, and Ulla Pfeffera, and Axel Dost, and Antje Herbst, and Antje Herbstc, and Ina Knerr, and Reinhard Holl
September 2003, Acta diabetologica,
Dieter Weitzel, and Dieter Weitzela, and Ulla Pfeffer, and Ulla Pfeffera, and Axel Dost, and Antje Herbst, and Antje Herbstc, and Ina Knerr, and Reinhard Holl
November 1987, Schweizerische medizinische Wochenschrift,
Dieter Weitzel, and Dieter Weitzela, and Ulla Pfeffer, and Ulla Pfeffera, and Axel Dost, and Antje Herbst, and Antje Herbstc, and Ina Knerr, and Reinhard Holl
October 1998, Acta paediatrica (Oslo, Norway : 1992). Supplement,
Dieter Weitzel, and Dieter Weitzela, and Ulla Pfeffer, and Ulla Pfeffera, and Axel Dost, and Antje Herbst, and Antje Herbstc, and Ina Knerr, and Reinhard Holl
January 2023, Indian journal of endocrinology and metabolism,
Dieter Weitzel, and Dieter Weitzela, and Ulla Pfeffer, and Ulla Pfeffera, and Axel Dost, and Antje Herbst, and Antje Herbstc, and Ina Knerr, and Reinhard Holl
January 1984, Minerva endocrinologica,
Dieter Weitzel, and Dieter Weitzela, and Ulla Pfeffer, and Ulla Pfeffera, and Axel Dost, and Antje Herbst, and Antje Herbstc, and Ina Knerr, and Reinhard Holl
June 2010, Zhonghua er ke za zhi = Chinese journal of pediatrics,
Dieter Weitzel, and Dieter Weitzela, and Ulla Pfeffer, and Ulla Pfeffera, and Axel Dost, and Antje Herbst, and Antje Herbstc, and Ina Knerr, and Reinhard Holl
August 2016, Pediatric diabetes,
Copied contents to your clipboard!